CANCERBAE CIC

Company limited by guarantee

Company Registration Number:
15850109 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2025

Period of accounts

Start date: 22 July 2024

End date: 31 July 2025

CANCERBAE CIC

Contents of the Financial Statements

for the Period Ended 31 July 2025

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

CANCERBAE CIC

Profit And Loss Account

for the Period Ended 31 July 2025

2025


£
Turnover: 5,770
Cost of sales: ( 14,906 )
Gross profit(or loss): (9,136)
Distribution costs: ( 91 )
Administrative expenses: ( 445 )
Other operating income: 11,902
Operating profit(or loss): 2,230
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: 2,230
Tax: 0
Profit(or loss) for the financial year: 2,230

CANCERBAE CIC

Balance sheet

As at 31 July 2025

Notes 2025


£
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks:   0
Debtors: 3 850
Cash at bank and in hand: 1,380
Investments:   0
Total current assets: 2,230
Prepayments and accrued income: 0
Creditors: amounts falling due within one year:   0
Net current assets (liabilities): 2,230
Total assets less current liabilities: 2,230
Total net assets (liabilities): 2,230
Members' funds
Profit and loss account: 2,230
Total members' funds: 2,230

The notes form part of these financial statements

CANCERBAE CIC

Balance sheet statements

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 19 May 2026
and signed on behalf of the board by:

Name: Dr Elisabeth (Lizzie) Gale
Status: Director

The notes form part of these financial statements

CANCERBAE CIC

Notes to the Financial Statements

for the Period Ended 31 July 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CANCERBAE CIC

Notes to the Financial Statements

for the Period Ended 31 July 2025

  • 2. Employees

    2025
    Average number of employees during the period 0

CANCERBAE CIC

Notes to the Financial Statements

for the Period Ended 31 July 2025

3. Debtors

2025
£
Trade debtors 0
Prepayments and accrued income 0
Other debtors 850
Total 850
Debtors due after more than one year: 0

COMMUNITY INTEREST ANNUAL REPORT

CANCERBAE CIC

Company Number: 15850109 (England and Wales)

Year Ending: 31 July 2025

Company activities and impact

The first trading year, running to 31 July 2025, was primarily a year of building: establishing infrastructure, listening to the community, forging partnerships, and beginning to translate CancerBae's vision into tangible activity. - Cancerbae Classic - The Classic is the UK's only national under-12 youth basketball showcase, and in itsfirst year it drew 140 plus young athletes, 24 coaches, and over 500 spectators, generating over 1 mil- lion social media impressions and receiving coverage from BBC, ITV, London Live, and ESPN. This event raised over £6000 for Cancer Research UK - Across his social media platforms, Will runs an ongoing street interview campaign in which he speaks with members of the public about cancer, their fears, their assumptions, their experiences, and at the close of each video reveals that he himself is living with stage 4 cancer. The impact is visible and documented. He has also run viral dance challenges and social media trends that have drawn in celebrities, bringing the #cancerbae message to audiences who would never engage with traditional cancer awareness campaigns. -We also heard clearly that children and siblings of people living with cancer represent a significantly underserved group. Young people who met Will at the Classic told us that seeing someone living with stage 4 cancer still showing up, still building, still choosing joy, changed how they thought about their parent's diagnosis. One child said: "If Will can do it, then I know my dad can." We have begun working with educational psychologists to design tailored, age-appropriate support for siblings of people living with cancer, a gap the community identified and that we are committed to addressing. - We have established a handmade merchandise line, creating products that generate income for the CIC while also providing opportunities for families and young people to participate in making work- shops. Across this first year we have worked to build credibility and presence within the broader cancer sector. We became a charity partner of Battle Cancer, an established national fundraising event, taking our place alongside some of the most recognised cancer organisations in the UK. We have built relationships with key leaders and stakeholders across health, sport, and community sectors, collaborated with other people living with cancer, and engaged with cancer charities whose missions complement our own. We have also been active in building relationships with local stakeholders, including our local MP.

Consultation with stakeholders

CancerBae CIC's stakeholders include people living with cancer at all stages, families and young people connected to the cancer community, siblings and children of people living with cancer, community members who have not yet been diagnosed but whose lives are touched by cancer, cancer sector organisations, health and education professionals, and the broader public reached through Will's awareness campaigns. A significant portion of our first year has been qualitative and relational. We have been listening carefully to people living with cancer, to families, and to young people, to understand what they actually need rather than what we assume they need. What we heard consistently was that people want access to spaces that do not feel clinical. They want to be around others who understand what it is like to live with cancer, without being required to talk about it. They described a need for somewhere you can simply turn up, have a cup of tea, do crafts, play a game, and know that the people around you understand, even if nothing is said. This feedback has directly shaped our plans for community social events, and we have begun working with partners to bring these kinds of gatherings to local communities. We also heard clearly that children and siblings of people living with cancer represent a significantly underserved group. Young people who met Will at the Classic told us that seeing someone living with stage 4 cancer still showing up, still building, still choosing joy, changed how they thought about their parent's diagnosis. One child said: "If Will can do it, then I know my dad can." We have begun working with educational psychologists to design tailored, age-appropriate support for siblings of people living with cancer, a gap the community identified and that we are committed to addressing.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
19 May 2026

And signed on behalf of the board by:
Name: Dr Elisabeth (Lizzie) Gale
Status: Director